Application of long non-coding RNA PRALR in the diagnosis of paclitaxel chemotherapy resistance in tumors
A tumor, drug resistance technology, applied in the field of biomedicine, can solve problems such as insufficient research
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] 1 material
[0024] RNAiso Plus total RNA extraction reagent (Takara 9109);
[0025] RNA Reverse Transcription Kit (ROCHE 04897030001);
[0026] SYBgreen method qPCR kit (ROCHE 04913914001);
[0027] High-fidelity enzyme PrimeSTAR Max DNA Polymerase (Takara R045A);
[0028] RACE 5' / 3' Kit (TAKARA 634858).
[0029] 2 methods
[0030] 2.1 Identification of the full-length sequence of the new transcript of TCONS_00013523
[0031] 2.1.1 Design of 5'RACE and 3'RACE amplification primers
[0032] The human lncRNA TCONS_00013523 sequence was downloaded from the UCSC database, and primers for nested PCR were designed for 5'RACE and 3'RACE amplification. The amplification primers were synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd., and the primer sequences are shown in Table 1.
[0033] Table 1 Sequences of primer pairs amplified by 5'RACE and 3'RACE
[0034]
[0035] 2.1.2 5'RACE and 3'RACE amplification and sequencing
[0036] see The RACE 5' / 3'Kit (TA...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com